Colgate Palmolive Co (CL) stock
CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 9/3028% above fair value
$97.90−0.10 (-0.10%)
Close on Nov 12, 2026Market cap $77.82BP/E 38.4Yield 2.12%
Colgate Palmolive ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Colgate Palmolive's ebitda for the twelve months ending Sep 30, 2026 was $3.80B, down 22.1% year over year. For fiscal 2025 it was $3.94B, down 19.2% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $4.87B in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.94B | -19.2% |
| FY2024 | Dec 31, 2024 | $4.87B | +7.1% |
| FY2023 | Dec 31, 2023 | $4.55B | +32.4% |
| FY2022 | Dec 31, 2022 | $3.44B | -11.6% |
| FY2021 | Dec 31, 2021 | $3.89B | -12.1% |
| FY2020 | Dec 31, 2020 | $4.42B | +8.6% |
| FY2019 | Dec 31, 2019 | $4.07B | -3.1% |
| FY2018 | Dec 31, 2018 | $4.21B | +0.5% |
| FY2017 | Dec 31, 2017 | $4.18B | -4.9% |
| FY2016 | Dec 31, 2016 | $4.40B | +35.8% |
| FY2015 | Dec 31, 2015 | $3.24B | -19.0% |
| FY2014 | Dec 31, 2014 | $4.00B | +0.1% |
| FY2013 | Dec 31, 2013 | $4.00B | -7.4% |
| FY2012 | Dec 31, 2012 | $4.31B | +1.2% |
| FY2011 | Dec 31, 2011 | $4.26B | +10.3% |
| FY2010 | Dec 31, 2010 | $3.87B | -2.5% |
| FY2009 | Dec 31, 2009 | $3.97B | +15.0% |
| FY2008 | Dec 31, 2008 | $3.45B | +12.9% |
| FY2007 | Dec 31, 2007 | $3.05B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.25B | +2.5% |
| Q2 FY2026 | Jun 30, 2026 | $1.17B | -4.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.12B | -8.5% |
| Q4 FY2025 | Dec 31, 2025 | $265.00M | -78.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.22B | +0.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.23B | -1.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.22B | +2.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.21B | -0.9% |
| Q3 FY2024 | Sep 30, 2024 | $1.22B | +3.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.25B | +11.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.20B | +15.4% |
| Q4 FY2023 | Dec 31, 2023 | $1.22B | +262.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.17B | +8.5% |
| Q2 FY2023 | Jun 30, 2023 | $1.12B | +9.5% |
| Q1 FY2023 | Mar 31, 2023 | $1.04B | +3.9% |
| Q4 FY2022 | Dec 31, 2022 | $337.00M | -33.5% |
| Q3 FY2022 | Sep 30, 2022 | $1.08B | -2.3% |
| Q2 FY2022 | Jun 30, 2022 | $1.02B | -9.8% |
| Q1 FY2022 | Mar 31, 2022 | $998.00M | -12.5% |
| Q4 FY2021 | Dec 31, 2021 | $507.00M | -54.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.11B | -3.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.13B | +5.0% |
| Q1 FY2021 | Mar 31, 2021 | $1.14B | +5.2% |
| Q4 FY2020 | Dec 31, 2020 | $1.11B | +4.1% |
| Q3 FY2020 | Sep 30, 2020 | $1.15B | +16.8% |
| Q2 FY2020 | Jun 30, 2020 | $1.08B | +6.2% |
| Q1 FY2020 | Mar 31, 2020 | $1.09B | +7.7% |
| Q4 FY2019 | Dec 31, 2019 | $1.06B | +4.6% |
| Q3 FY2019 | Sep 30, 2019 | $986.00M | -1.5% |
| Q2 FY2019 | Jun 30, 2019 | $1.02B | -5.5% |
| Q1 FY2019 | Mar 31, 2019 | $1.01B | -9.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.02B | -5.9% |
| Q3 FY2018 | Sep 30, 2018 | $1.00B | -7.7% |
| Q2 FY2018 | Jun 30, 2018 | $1.08B | +8.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.11B | +8.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.08B | -8.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.09B | – |
| Q2 FY2017 | Jun 30, 2017 | $995.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.02B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.19B | – |
See a number that looks wrong?